Jacqueline M Kraveka Selected Research

APO protocol 2

1/2005

Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacqueline M Kraveka Research Topics

Disease

11	Neuroblastoma 11/2022 - 11/2003
9	Neoplasms (Cancer) 11/2022 - 05/2012
2	Medulloblastoma 01/2022 - 05/2012
2	Squamous Cell Carcinoma of Head and Neck 01/2017 - 12/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2013 - 01/2013
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2022
1	Alveolar Rhabdomyosarcoma 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Farber Lipogranulomatosis 12/2018
1	Prostatic Neoplasms (Prostate Cancer) 12/2015
1	Inflammation (Inflammations) 12/2015
1	Infections 12/2014
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2014
1	Neutropenia 12/2014
1	Hypoxia (Hypoxemia) 09/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2005
1	Lymphoma (Lymphomas) 01/2005
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2004
1	Hypercalcemia (Milk Alkali Syndrome) 07/2004

Drug/Important Bio-Agent (IBA)

6	dihydroceramide desaturaseIBA 01/2017 - 06/2007
5	CeramidesIBA 01/2013 - 11/2003
4	SphingolipidsIBA 01/2017 - 05/2012
3	EnzymesIBA 12/2018 - 06/2007
2	Caspase 3 (Caspase-3)IBA 01/2017 - 12/2013
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2015 - 05/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2013 - 01/2013
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Eflornithine (Ornidyl)FDA Link 11/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	TB-403IBA 01/2022
1	Neuropilin-1IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	PlatinumIBA 12/2021
1	Temozolomide (Temodar)FDA LinkGeneric 12/2021
1	LCL521IBA 12/2018
1	Acid CeramidaseIBA 12/2018
1	Biological FactorsIBA 03/2018
1	fumonisin B1IBA 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 12/2015
1	3- (4- chlorophenyl)- adamantane- 1- carboxylic acid (pyridin-4-ylmethyl)amideIBA 12/2015
1	SphingosineIBA 12/2015
1	sphingosine kinaseIBA 12/2015
1	Phosphotransferases (Kinase)IBA 12/2015
1	PolyaminesIBA 01/2015
1	Vinblastine (Vinblastine Sulfate)FDA Link 12/2014
1	SiliconesIBA 12/2013
1	phthalocyanineIBA 12/2013
1	Photosensitizing Agents (Photosensitizers)IBA 12/2013
1	Dasatinib (BMS 354825)FDA Link 12/2013
1	silicon phthalocyanineIBA 01/2013
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2013
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 05/2012
1	cyclopamineIBA 05/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2012
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 05/2012
1	FenretinideIBA 07/2011
1	SphingomyelinsIBA 09/2008
1	Cytochromes c (Cytochrome c)IBA 09/2008
1	methyl(arginyl)- lysyl- prolyl- tryptophyl- tert- leucyl- leucineIBA 09/2008
1	Prednisone (Sone)FDA LinkGeneric 01/2005
1	Methotrexate (Mexate)FDA LinkGeneric 01/2005
1	Vincristine (Oncovin)FDA LinkGeneric 01/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2005
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2005
1	Pamidronate (Aredia)FDA LinkGeneric 07/2004
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 07/2004
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2003
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2003

Therapy/Procedure

8	Therapeutics 11/2022 - 05/2012
3	Immunotherapy 11/2022 - 01/2019
2	Photochemotherapy (Photodynamic Therapy) 12/2013 - 01/2013
1	Drug Therapy (Chemotherapy) 12/2021
1	Induction Chemotherapy 01/2019
1	Castration 12/2015
1	Drug Tapering 12/2014
1	APO protocol 2 01/2005